NOXOPHARM LIMITED – TRADING HALT The Company requests a trading halt effective immediately pending the release of an announcement, anticipated today, clarifying the Company’s position on an ASX release made by Kazia Therapeutics Limited after close of trading on 22 November 2017. The trading halt is requested until the earlier of the release of an announcement regarding the clarification, or prior to the opening of trading on Monday 27 November 2017. The Company is not aware of any reason why the trading halt should not be granted. Thank you for your assistance. If you have any questions please contact the Company Secretary, David Franks on (02) 9299 9690. For and on behalf of the Board, Yours faithfully,
NRT Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
